Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Feasibility of Fluorescence Targeted Pelvic Lymph Node Mapping During Rectal Cancer Surgery

NCT03204994 is registered in ClinicalTrials.gov with Oxford University Hospitals NHS Trust as lead sponsor.

NCT NCT03204994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03204994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Feasibility of Fluorescence Targeted Pelvic Lymph Node Mapping During Rectal Cancer Surgery
Lead sponsor
Oxford University Hospitals NHS Trust
Phase
Phase 1/2
Overall status
Terminated
Start date
August 1, 2017
Completion date
August 1, 2018
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of rectum, lymph node disease